Physician profile
Colvert Gonzales
NPI 1043574197
$1,003.91
in general payments reported to CMS, 2019-2025
10 companies · $615 in 2025
The $615 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $78.24 · 2021: $11.29 · 2022: $109 · 2023: $151 · 2024: $40.19 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737 · Entertainment: $68.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.10 |
| Entertainment | $68.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $344.63 | 2024-2025 | Hydrus Microstent, Voyager Dslt, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $200.74 | 2020-2025 | Acuvue |
| Rxsight INC | $137.96 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Coopervision INC. | $102.18 | 2020-2023 | Myday Contact Lens |
| Optos, INC. | $68.45 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $60.06 | 2022-2025 | Infuse |
| Sight Sciences, INC. | $40.65 | 2023 | Tearcare System |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $15.02 | 2022 | |
| Plexus Optix, INC. | $14.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colvert Gonzales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.